DISCOVERY OF A LIVER TARGETED ORAL PD-L1 SMALL MOLECULE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS B AND LIVER CANCER

被引：0

作者：

Roose, Heleen ^{[1
]}

Rekstyte-Matiene, Kristina ^{[1
]}

Stevens, Sarah K. ^{[2
]}

Gupta, Kusum ^{[2
]}

Chang, Sandra ^{[2
]}

Liu, Cheng ^{[2
]}

Serebryany, Vladimir ^{[2
]}

Adame, Lillian ^{[2
]}

Le, Kha ^{[2
]}

Stoycheva, Antitsa ^{[2
]}

Blatt, Lawrence M. ^{[2
]}

Beigelman, Leonid N. ^{[2
]}

Chanda, Sushmita ^{[2
]}

Smith, David B. ^{[2
]}

Symons, Julian ^{[2
]}

Jekle, Andreas ^{[2
]}

Wu, Tongfei ^{[1
]}

机构：

[1] Aligos Belgium BV, Leuven, Belgium

[2] Aligos Therapeut Inc, San Francisco, CA USA

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1466-C

引用

页码：S566 / S567

页数：2

共 50 条

[1] DISCOVERY OF LIVER-TARGETED ORAL PDL1 SMALL MOLECULE INHIBITORS FOR THE TREATMENT OF CHRONIC HEPATITIS B AND LIVER CANCERS
Wu, Tongfei
Stevens, Sarah K.
Liu, Cheng
Roose, Heleen
Rekstyte-Matiene, Kristina
Behaeghel, Elke
Mukherjee, Sucheta
Chang, Sandra
Jaisinghani, Ruchika
Stoycheva, Antitsa
Zhang, Qingling
Gupta, Kusum
Jekle, Andreas
Deval, Jerome
Symons, Julian A.
Blatt, Lawrence M.
Beigelman, Leonid N.
Raboisson, Pierre
Gonzalvez, Francois
HEPATOLOGY, 2022, 76 : S25 - S26
[2] ORAL SMALL-MOLECULE LIVER-TROPIC PD-L1 INHIBITOR PHARMACOKINETICS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
Mondal, Arpita
Thi, Emily P.
Graves, Ingrid
Heffernan, Gavin
Xu, Fran
Ozturk, Seyma
Pohl, Amanda
Fan, Kristi Y.
Cole, Andrew
Harasym, Troy
Lam, Angela M.
Sofia, Michael J.
HEPATOLOGY, 2023, 78 : S1946 - S1947
[3] Small-molecule inhibitor PD-1 /PD-L1 interaction for colorectal cancer treatment
Anaya-Ruiz, Maricruz
Perez-Santos, Martin
PHARMACEUTICAL PATENT ANALYST, 2021, 10 (06) : 245 - 250
[4] Discovery and characterization of a novel small molecule brain penetrant PD-L1 inhibitor
Zhang, Yongxian
Zhang, Mingming
Zhao, Baowei
Yu, Hongping
Xu, Yao-Chang
Chen, Zhui
Ying, Haiyan
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[5] Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
Jin, Shengzhe
Wang, Hongfei
Li, Yang
Yang, Jingwen
Li, Beibei
Shi, Peishang
Zhang, Xiangrui
Zhou, Xiaowen
Zhou, Xiuman
Niu, Xiaoshuang
Wu, Menghan
Wu, Yahong
Zhai, Wenjie
Qi, Yuanming
Gao, Yanfeng
Zhao, Wenshan
CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
[6] Preclinical pharmacokinetic, pharmacodynamic and efficacy relationships of ALG-093702, a liver targeted PD-L1 small molecule inhibitor, in different in vivo models
Roose, Heleen
Zhang, Qingling
Le, Kha
Jekle, Andreas
Rekstyte-Matiene, Kristina
Stevens, Sarah
Jaisinghani, Ruchika
Liu, Cheng
Chang, Sandra
Stoycheva, Antitsa
Blatt, Lawrence
Beigelman, Leonid
Symons, Julian
Chanda, Sushmita
Gonzalvez, Francois
Wu, Tongfei
JOURNAL OF HEPATOLOGY, 2023, 78 : S1030 - S1031
[7] Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
Shengzhe Jin
Hongfei Wang
Yang Li
Jingwen Yang
Beibei Li
Peishang Shi
Xiangrui Zhang
Xiaowen Zhou
Xiuman Zhou
Xiaoshuang Niu
Menghan Wu
Yahong Wu
Wenjie Zhai
Yuanming Qi
Yanfeng Gao
Wenshan Zhao
Cell Communication and Signaling, 22
[8] YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer
Fangfang Lai
Ming Ji
Lei Huang
Yunchen Wang
Nina Xue
Tingting Du
Kai Dong
Xiaoqing Yao
Jing Jin
Zhiqiang Feng
Xiaoguang Chen
ActaPharmaceuticaSinicaB, 2022, 12 (06) : 2845 - 2858
[9] YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer
Lai, Fangfang
Ji, Ming
Huang, Lei
Wang, Yunchen
Xue, Nina
Du, Tingting
Dong, Kai
Yao, Xiaoqing
Jin, Jing
Feng, Zhiqiang
Chen, Xiaoguang
ACTA PHARMACEUTICA SINICA B, 2022, 12 (06) : 2845 - 2858
[10] Discovery and characterization of a novel small molecule antagonist of PD-L1
Ying, Haiyan
Yang, Fei
Zhang, Mingming
Zhang, Yongxian
Zhao, Yuan
Chen, Xin
Zhang, Lei
Yu, Hongping
Chen, Zhui
Xu, Yao-chang
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)

← 1 2 3 4 5 →